Jeremy S. Abramson MD, MMSc

Jeremy S. Abramson, MD, MMSc, is Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center and Associate Professor of Medicine at Harvard Medical School.

Dr. Abramson earned his medical degree from the Mount Sinai School of Medicine in New York and a master’s degree of medical science in clinical investigation from Harvard Medical School. He completed his residency in internal medicine at the Massachusetts General Hospital, as well as a fellowship in hematology and oncology at Dana-Farber Cancer Institute.

Dr. Abramson’s primary clinical interest is the management of lymphoma and chronic lymphocytic leukemia. His research focuses on optimal treatment of lymphoid malignancies, including development of novel targeted therapies and cellular immunotherapies for these diseases.

Dr. Abramson serves on the NCCN CLL/SLL/Hairy Cell Leukemia Panel and the NCCN B-Cell Lymphoma Panel.